window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 9, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

advanced therapies

  • Advanced Therapies,Drug Discovery & Development

    Cartesian licenses WestGene platform to advance in vivo CAR-T for autoimmune diseases

    Cartesian Therapeutics has signed a strategic licensing agreement with WestGene [...]

    June 9, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    CuraCell reports pancreatic cancer findings from personalised TIL therapy programme

    CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

    June 8, 2026
  • Advanced Therapies,Drug Discovery & Development,Medical devices

    Crowdhelix launches regenerative medicine network to support bioprinted cornea research

    Crowdhelix has launched a new international innovation network focused on [...]

    June 8, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    ELRIG announces keynotes for inaugural Cell and Gene Therapy 2026 conference

    ELRIG has unveiled the keynote speakers for its inaugural Cell [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    eXmoor Pharma and Siam Bioscience partner to expand cell and gene therapy services in Southeast Asia

    eXmoor Pharma and Siam Bioscience have announced a strategic partnership [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory

    Vitalant and UPMC expand partnership to advance cell and gene therapy initiatives

    Vitalant, a national blood and biotherapies provider, is expanding its [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    Adva Biotechnology and Autolomous launch program to scale digital manufacturing of autologous cell therapies

    Adva Biotechnology and Autolomous have announced a collaboration to co-lead [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Galapagos taps CELLforCURE by SEQENS to manufacture CAR-T therapy in France

    CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory

    UK experts urge Government to appoint Minister for cell and gene therapies

    Commission sets out 25 policy recommendations to unlock access and [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CuraCell reports pancreatic cancer findings from personalised TIL therapy programme
    Categories: Advanced Therapies, Clinical & Regulatory, Therapeutic Areas
  • Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology
    Categories: Drug Delivery & Formulation, Medical devices, Pharmaceuticals and therapeutics
  • Apoha raises $36M to expand molecular behaviour data platform
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top